Abstract:
The invention relates to a dipeptide conjugate having general formula I, AA2-AA1-NH 2 , wherein A represents the radical corresponding to a monocarboxylic acid with general formula II, HOOC-R, in which: R represents a linear or branched aliphatic radical at C 1 -C 24 , which is optionally substituted by a hydroxyl group and which can comprise one or more unsaturations, preferably between 1 and 6 unsaturations, and/or which can comprise a phenyl group or lipoic acid or the reduced form thereof, dihydrolipoic acid or N-lipoyllysine; and AA1 and AA2 represent identical or different amino acids which are selected from the group containing Ala, Asn, Cys, Gln, Gly, Ile, Leu, Met, Phe, Pro, Ser, Thr, Trp, Tyr, Val, Asp, Glu, Arg, His, Lys, Orn, Dap, Dab, the corresponding homo-amino acids and the corresponding beta-amino acids in the form of enantiomers or diastereoisomers and mixtures thereof, including racemic mixtures.
Abstract translation:本发明涉及具有通式I,AA2-AA1-NH 2的二肽缀合物,其中A表示对应于通式II的单羧酸HOOC-R的基团,其中:R表示 C 1 -C 12的直链或支链脂肪族基团,其任选被羟基取代,并且可以包含一个或多个不饱和度,优选1至6个不饱和度 ,和/或其可以包含苯基或硫辛酸或其还原形式,二氢硫辛酸或N-脂酰赖氨酸; AA1和AA2代表相同或不同的氨基酸,其选自含有Ala,Asn,Cys,Gln,Gly,Ile,Leu,Met,Phe,Pro,Ser,Thr,Trp,Tyr,Val,Asp,Glu ,Arg,His,Lys,Orn,Dap,Dab,相应的同型氨基酸和对映异构体或非对映异构体形式的相应β-氨基酸及其混合物,包括外消旋混合物。
Abstract:
The present invention relates to the use of a silicon-based porous catalytic system for oligomerising light olefins said porous silicon-based catalytic system having an average pore diameter of between about 1 nm and about 5 nm and an acidity level of between about 150 µmol/g and about 650 µmol/g, and prepared from at least one hydrolysable silicon-based compound, or other source of silicon, and at least one non-ionic surface active agent.The invention also relates to a process for oligomerising light olefins using said silicon-based porous catalytic system, and to certain silicon-based porous catalytic systems.
Abstract:
The present invention relates to the use of a silicon-based porous catalytic system for oligomerising light olefins said porous silicon-based catalytic system having an average pore diameter of between about 1 nm and about 5 nm and an acidity level of between about 150 µmol/g and about 650 µmol/g, and prepared from at least one hydrolysable silicon-based compound, or other source of silicon, and at least one non-ionic surface active agent.The invention also relates to a process for oligomerising light olefins using said silicon-based porous catalytic system, and to certain silicon-based porous catalytic systems.
Abstract:
The invention concerns a method for synthesizing styryl isoxazole, styryl pyrazole and styryl isothazole derivatives in a synthesis step followed by a recrystallization in a basic alcohol medium.
Abstract:
Process of preparation of silicon-based multifunctional catalytic systems synthesised together with one or more surface active agents, 2) multifunctional silicon-based porous catalytic system comprising at least one porous catalytic support structurally comprising silica and at least one other metal or non-metal oxide chosen from aluminium, zirconium, and boron, said catalytic support being synthesised together with one or more surface active agents, and at least one or more catalyst chosen from among metallic elements of groups 6-10 of the periodic table of the elements, 3) the catalytic systems are useful in hydrogenation and/or decyclisation reactions of (poly)aromatic compounds, especially for improving the quality of diesel fuels and increasing their cetane number.
Abstract:
Novel method for peptide synthesis using an N-[N'-nitroso-(R')carbamoyl]amino acid as the starting compound. The compound is separated into N2, R'OH and N-carboxyanhydride of formula (II). The compound (II) together with an amino acid or peptide with at least one free alpha -amino function is introduced into a reactive medium to obtain a dipeptide or a higher peptide than the added peptide. 00000
Abstract:
The invention relates to biosourced epoxide resins including the product of the reaction of one or more biosourced epoxide lipid derivatives with at least one cross-linking agent in the presence of at least one co-reagent selected from among the glycidyl ether derivatives of biosourced polyols, or the product of the reaction of one or more glycidyl ether derivatives of biosourced polyols with at least one cross-linking agent.
Abstract:
Provided herein are compounds, compositions and methods for the treatment of liver disorders, including liver cancer and metabolic diseases, such as diabetes, hyperlipidemia, atherosclerosis, and obesity. Specifically, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-cancer agents.
Abstract:
The invention concerns materials based on a woven or non-woven textile substrates coated with a matrix, characterized in that the matrix comprises one or more biodegradable polymers for controlled emission of one or more volatile antimicrobial agents incorporated in said polymers. The invention is useful in particular tor protecting products against the activity or development of microorganisms.
Abstract:
The invention concerns a pharmaceutical composition comprising compounds of formula (I): NZ 1 Z 2 Z 3 , wherein: Z 1 , Z 2 , Z 3 , independently represent: a hydrogen atom; a C 1 -C 6 alkyl group; a -SO 2 R 3 where R 3 represents a linear or branched C 1 -C 12 alkyl, alkenyl or alkynyl group, a C 3 -C 10 cycloalkyl group or a C 6 -C 10 aryl group, a (C 1 -C 6 ) alkyl (C 6 -C 14 ) aryl group, a heteroaryl group in C 5 -C 10 , provided that at least one of the Z 1 , Z 2 , Z 3 represents a group of formula (II) X-R F -(CH 2 ) n -SO 2 -, X, R F and n being such as defined in claim 1; excluding compounds for formula (I) wherein n=0 and at least one of the Z 1 , Z 2 , Z 3 groups represents CF 3 ; as well as excluding the compound (C 8 F 17 ) (C 2 H 5 )NH
Abstract translation:本发明涉及包含式(I)化合物的药物组合物:NZ 1 Z 2 Z 3 Z 3,其中:Z < Z 1,Z 2,Z 3,Z 3独立地表示:氢原子; C 1 -C 6烷基; C 1 -C 6烷基; 其中R 3代表直链或支链C 1 -C 12烷基,其中R 3代表直链或支链C 1 -C 12 - C 1 -C 6烷基,链烯基或炔基,C 3 -C 10环烷基或C 6 -C 10 芳基,(C 1 -C 6 -C 6)烷基(C 6 -C 14)烷基(C 1 -C 6 - )芳基,C 5 -C 10的杂芳基,条件是Z 1,Z 2中的至少一个 Z 3表示式(II)的基团XR 1 - (CH 2 N 2)n SUB > -SO 2 - ,X,R F和n如权利要求1所定义; 不包括其中n = 0的式(I)化合物和Z 1,Z 2,Z 3 3个基团中的至少一个表示CF 3, SUB> 3 SUB>; 以及不包括化合物(C 13 H 17)NH 3(CH 2 CH 2)NH